🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SFIX and executed a BUY strategy, securing a +31.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$4503.T

Astellas Pharma Inc.

JapanJAPAN
FREE PREVIEW
AVG HISTORICAL GAP-0.12%
MAX GAP RECORD-1.84%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY0.7%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Astellas Pharma Inc. manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric cancer; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also provides VEOZAH, a treatment for vasomotor symptoms due to menopause; IZERVAY, a treatment… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL